Next report date
Report period
H1 2024
EPS estimate
—
Revenue estimate
—
−18.55 MCHF
65.90 M
About SPEXIS N
Sector
CEO
Jeffrey D. Wager
Headquarters
Allschwil
Website
Employees (FY)
28
Founded
1996
ISIN
CH0106213793
FIGI
BBG00KK1Z4L0
Spexis Ltd. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of respiratory therapeutics. The firm focuses on rare, chronic respiratory diseases (CRD) and chronic lung infections in cystic fibrosis. Its product pipeline includes ColiFin, Inhaled Murepavadin, Balixafortide (POL6326), OMPTA, EBX-002, and POL6014 (Lonodelestat). The company was founded by Daniel Obrecht and Jean-Pierre Obrecht in 1996 and is headquartered in Allschwil, Switzerland.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of SPEX is 0.0590 CHF — it has increased by 0.34% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SIX exchange SPEXIS N stocks are traded under the ticker SPEX.
SPEXIS N is going to release the next earnings report on Sep 5, 2024. Keep track of upcoming events with our Earnings Calendar.
SPEX stock is 6.88% volatile and has beta coefficient of −1.95. Check out the list of the most volatile stocks — is SPEXIS N there?
Yes, you can track SPEXIS N financials in yearly and quarterly reports right on TradingView.
SPEX stock has risen by 6.88% compared to the previous week, the month change is a 21.33% fall, over the last year SPEXIS N has showed a 84.95% decrease.
Today SPEXIS N has the market capitalization of 3.99 M, it has increased by 4.73% over the last week.
No, SPEX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, SPEX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SPEXIS N stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 28, 2024, the company has 28.00 employees. See our rating of the largest employees — is SPEXIS N on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SPEXIS N technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SPEXIS N stock shows the strong sell signal. See more of SPEXIS N technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.